This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ChatGPT shows potential for diagnosingnuclearmedicine cases, yet needs further development before it can be implemented in practice, according to a study presented November 28 at RSNA in Chicago. and ChatGPT-4 to the test on nuclearmedicine differential diagnoses cases transcribed from two textbooks.
Under the new policy, CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630, removing financial barriers that have long hindered patient access to essential nuclearmedicine diagnostic procedures.
A new PET radiotracer shows promise for diagnosing triple-negative breast cancer, researchers at Fudan University Shanghai Cancer Center in China have reported. The study was published February 13 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
Multiparametric MRI (mpMRI) is a widely used approach for diagnosing patients with prostate cancer and reduces the need for invasive biopsies in approximately 30% of cases, Brembilla explained. Our preliminary data confirmed the potential increase of sensitivity of the combined use of PSMA PET with MRI compared to each modality alone.
F-18 FAPI-PET/CT is superior to F-18 FDG-PET/CT for diagnosing and staging patients with pancreatic cancer, according to a study published January 4 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine. Tumor is marked by arrows. DWI = diffusion-weighted imaging.
The Society of NuclearMedicine and Medical Imaging (SNMMI) is praising the U.S. NETs are diagnosed and treated with nuclearmedicine imaging. Senate for including neuroendocrine tumors (NETs) in the fiscal year 2025 Senate Defense Appropriations report.
PET/CT imaging using gallium-68 (Ga-68) Fibroblast activation protein inhibitor (FAPI) radiotracer over F-18 FDG appears promising in women with invasive lobular carcinoma (ILC), according to a study published March 14 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
We highlight some of the recent accomplishments in research and clinical trials by members of the department who apply nuclearmedicine to diagnose and treat illnesses including cancer.
PET/MRI imaging shows promise in diagnosing fevers or inflammation of unknown origin and may have advantages over PET/CT, according to a study published January 3 in the European Journal of Radiology.
Currently, the CMS bundles Medicare payments for PET radiotracers for diagnosing disease as part of the packaged cost of imaging procedures in hospital outpatient settings. Mo-99 is the source material for Tc-99m, which is used in an estimated 40,000 nuclearmedicine diagnostic exams each day in the U.S.
We highlight some of the recent accomplishments in research and clinical trials by members of the department who apply nuclearmedicine to diagnose and treat illnesses including cancer.
PET/CT imaging with F-18 fluroestradiol (FES) can play a significant role helping clinicians make treatment decisions in patients with recurrent or metastatic breast cancer, according to a study published October 3 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
An emerging PET/CT radiotracer may be more predictive of progressive pulmonary fibrosis in interstitial lung patients than F-18 FDG PET/CT, according to research presented June 8 at the 2024 Society of NuclearMedicine and Molecular Imaging Annual Meeting (SNMMI).
A PET radiotracer for diagnosing Alzheimer’s disease may also be used to measure vascular brain changes in patients during PET/MRI scans, according to a study published December 7 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
TORONTO -- AuntMinnie.com spoke with cardiac PET imaging expert Krishna Patel, MD, from Mount Sinai in New York City, at the Society of NuclearMedicine and Molecular Imaging annual meeting. Women are 2.5 to three times more likely to suffer from INOCA and coronary artery microvascular disfunction than men.
PET/MRI could be a tool for diagnosing brain injury in young cancer survivors due to high-dose methotrexate treatment, according to pediatric radiologists at Stanford University in Stanford, CA. The study was published April 4 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
PET imaging using a newly developed radiotracer has identified different patterns of brain tau pathology over time in early-onset versus late-onset Alzheimer’s disease patients, according to a study published February 1 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
He was regarded as a receptive person who helped other doctors in the discussion of cases to reach diagnoses. Those who specialized -- particularly in CT, MRI, neuroimaging, and nuclearmedicine/PET -- earned more. Ferreira had reportedly retired three months prior to the trip.
PET/MRI scans have revealed immune system reactions after COVID-19 vaccines in children with cancer, according to a study published October 26 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine. The mean SUV max increased by a factor of three, from 0.87 before before vaccination to 2.61 after
A new PET radiotracer has the potential for visualizing responses in liver cancer patients undergoing immunotherapy, according to a study published December 12 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine. Nuclei were stained with 4,6-diamidino-2-phenylindole.
This is just the third year that RSNA has offered a dedicated track on nuclearmedicine and molecular imaging, with eight scientific sessions covering research in prostate cancer imaging, breast cancer, cardiovascular and pulmonary imaging, and more. Which approach is best in newly diagnosed breast cancer? 8:40 a.m. |
PET/CT imaging with F-18 sodium fluoride (NaF) is emerging as a sensitive tool for detecting early atherosclerosis, according to a presentation at the recent Society of NuclearMedicine and Molecular Imaging (SNMMI) annual meeting.
The group analyzed data from 47 patients diagnosed with advanced HGSOC who underwent pretreatment scans at their center between 2012 and 2020. To explore the additional value of the technique, the researchers thus analyzed the relationship between MTV and TLG on pretreatment F-18 FDG-PET/CT and clinical outcomes.
Nuclearmedicine and the future of precise, personalised care in diagnosing and treating diseases. The post NuclearMedicine at the Centre of Radiology and Radiopharmaceuticals appeared first on Open Medscience.
Di Carli noted that currently, SPECT MPI – also a nuclearmedicine imaging exam, but one that requires higher radiation doses to patients and produces less resolution – remains the workhorse in the field. The game-changer could be the pending U.S. approval of new PET radiotracers, such as F-18 flurpiridaz , he said.
A recently developed PET radiotracer identified sources of pain in patients with complex regional pain syndrome (CRPS) and led to effective treatments, according to a study presented June 10 at the Society of NuclearMedicine and Molecular Imaging (SNMMI) annual meeting. To that end, Baal and colleagues developed F-18 FTC-146.
Neuroimaging in nuclearmedicine allows for detailed visualisation of brain activity, aiding in diagnosing complex neurological conditions. The post Unlocking the Mysteries of the Brain: Neuroimaging in NuclearMedicine appeared first on Open MedScience.
“In melanoma patients, identification of those who are at higher risk of brain metastasis occurrence can be crucial as subsequent surveillance and even prophylactic treatment options can be provided,” wrote lead author and nuclearmedicine physician Forough Kalantari, MD. Image courtesy of Cancers.
Nuclearmedicine technology firm Positrigo of Zurich, Switzerland, has secured European market clearance for its dedicated brain PET system, NeuroLF. The company received U.S.
Nuclearmedicine is a form of specialty medicine that uses radioactive tracers to evaluate bodily functions and to diagnose and treat a wide range of health conditions. Nuclear scans produce images of the body’s anatomy that cannot be obtained as clearly or fully with other imaging techniques.
PSMA-PET/CT has the potential to be an effective alternative imaging approach for diagnosing patients with renal cell carcinoma (RCC), a type of kidney cancer, according to a study published May 23 in the Journal of NuclearMedicine.
Importantly, we are gaining deeper insights into disease processes themselves, which enhances our ability to diagnose and potentially treat conditions that were previously beyond our reach." While the benefits have been clear in areas such as epilepsy and multiple sclerosis, these only hint at the broader potential of 7T MRI.
Radiologists are medical doctors who specialize in interpreting imaging studies like X-rays, CT scans, MRIs, and ultrasounds to diagnose and guide treatment for various conditions. For patients, this means: Timely diagnoses: Faster access to critical information, reducing delays in treatment.
A recent study highlighted by the Society for NuclearMedicine and Molecula. validated in prostate cancer patients PSMA-PET matches MRI, beats CT in diagnosing liver cancer PSMA-PET improves prostate cancer management in most patients Pylarify PET/MRI shows value in selecting patients for focal ablative therapy
A comparative analysis between FAPI and 18F-FDG PET/CT for the systemic staging of newly diagnosed breast cancer has demonstrated that FAPI PET/CT offers more accurate staging.
Two certified nuclearmedicine physicians with 17 and 5 years of experience independently analyzed the Ga-68 FAPI-PET/CT scans, with primary tumors and metastatic lesions confirmed as positive based on the intensity of the Ga-68 FAPI radiotracer signal.
A pair of articles published in the May issue of the Journal of NuclearMedicine illustrate the promise of the novel FAPI radiotracer in diagnosing, staging, and treating multiple types of cancer.
F-18 florbetaben PET scans for diagnosing Alzheimer’s disease can be reduced from 20 minutes to five minutes without losing accuracy, according to a recent study. F-18 florbetaben PET (Neuraceq, Life Molecular Imaging) PET scans are used widely to visualize beta-amyloid deposits in the brain, a key marker used to diagnose Alzheimer’s disease.
Currently, the CMS bundles Medicare payments for PET radiotracers for diagnosing disease as part of the packaged cost of imaging procedures in hospital outpatient settings. Mo-99 is the source material for Tc-99m, which is used in an estimated 40,000 nuclearmedicine diagnostic exams each day in the U.S.
New research reveals that a novel PET perfusion radiotracer can diagnose coronary artery disease in obese patients with superior sensitivity and specificity compared to 99mTc-SPECT myocardial perfusion imaging.
A novel PET imaging technique can noninvasively detect active inflammation in the body before clinical symptoms arise, according to research published in the February issue of The Journal of NuclearMedicine. This makes it easier for physicians to correctly diagnose and treat patients.
PET/CT imaging with a new gallium-68-based prostate cancer radiotracer shows promise for detecting recurrent metastatic disease, according to a study published February 20 in the Journal of NuclearMedicine. Images and caption courtesy of the Journal of NuclearMedicine. HU = Houndsfield unit; SUVbw = body-weight SUV.
In an interview at the recent Society of NuclearMedicine and Molecular Imaging (SNMMI) conference in Chicago, Jeremie Calais, M.D., MSc discussed promising research findings for the use of the positron emission tomography (PET) imaging agent 89ZR-DFO-girentuximab for diagnosing clear cell renal cell carcinoma.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content